Status:
COMPLETED
Effects and Safety of Taurine Granule on Blood Pressure in Prehypertensive
Lead Sponsor:
Zhiming Zhu
Conditions:
Prehypertension
Eligibility:
All Genders
25-75 years
Phase:
PHASE3
Brief Summary
Prehypertension are associated with an increased risk of atherosclerosis and coronary artery disease, and often complicated with the metabolic disorder of glucose and lipid. The comprehensive preventi...
Eligibility Criteria
Inclusion
- Blood pressure: 120mmHg≤SBP\<140mmHg.
Exclusion
- Diabetes
- Hypertension: SBP≥140mmHg, or DBP≥90mmHg.
- known allergy to trial drugs
- Myocardial infarction or cerebrovascular accident in the year preceding the trial
- Clinical Congestive Heart Failure
- Secondary hypertension
- Pregnancy or lactating women
- Malignant tumor
- Gastroesophageal reflux or gastroduodenal ulcer
- History of hepatitis or cirrhosis
- History of kidney disease
- Body weight﹤35Kg
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01816698
Start Date
December 1 2012
End Date
March 1 2015
Last Update
November 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The third hospital affiliated to the Third Military Medical University
Chongqing, Chongqing Municipality, China, 400042